Andreas Otte. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Antibodies, Monoclonal/therapeutic useClinical Trials as TopicHumansLymphoma, Non-Hodgkin/epidemiologyLymphoma, Non-Hodgkin/radiotherapyPractice Patterns, Physicians'/trendsPrognosisRadiopharmaceuticals/therapeutic useTreatment OutcomeYttrium Radioisotopes/therapeutic use
Substances: See more » Antibodies, MonoclonalRadiopharmaceuticalsYttrium Radioisotopesibritumomab tiuxetan
Year: 2006 PMID: 16794521 DOI: 10.1097/00006231-200607000-00008
Source DB: PubMed Journal: Nucl Med Commun ISSN: 0143-3636 Impact factor: 1.690